Skip to main content

Table 2 Patient mean survival time and Cox regression analysis of TMPRSS2-ERG fusion status

From: Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer

Fusion Status

Survival Time (SD)1

HR (95% CI)2

p-value

HR (95% CI)3

p-value

Negative

11.4 (3.1)

    

   Positive

12.0 (2.6)

2.4 (0.7 – 7.6)

0.3

1.2 (0.3 – 4.0)

0.8

Negative

11.4 (3.1)

    

   Translocation

12.0 (2.9)

    

   Deletion

12.0 (2.2)

1.5 (0.7 – 2.9)

0.3

1.2 (0.5 – 2.7)

0.5

Negative

11.4 (3.1)

    

   Single

12.1 (2.3)

    

   Multiple

11.5 (4.1)

1.9 (0.9 – 4.1)

0.09

1.5 (0.6 – 3.9)

0.9

  1. 1Time elapsed from diagnosis until death; 2Age adjusted; 3Age & Gleason score adjusted.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us